21 Sep Life Stem Genetics Inc (MIDYD) – soon to be LIFS – stock research report
Miami Days Corp (MIDY) just changed its name to Life Stem Genetics Inc and effected a 13:1 forward split. Everything about this one screams possible future paid promotion so we decided to initiate coverage of the ticker.
Miami Days Corp was set-up as a Nevada business entity on July 5, 2012 with Bojan Didic as the sole officer/director using a Miami, Florida address.
Bojan Didic (32) received a three year education from College of Hotel Management in Belgrade, Serbia. He then served 5 years as a Wine Steward on Cunard Cruise Lines before moving to the United States and becoming a Wine Steward at Mr. Chow restaurant in Tribeca in New York City from 2007 until 2008. Mr. Didic also worked as an assistant to General Manager in Mr. Chow Restaurant on Miami Beach from 2008 until 2012.
Bojan Didic was issued 4,000,000 shares of stock for $4,000 ($.001/share).
The forward looking business plan for Miami Days Corp was to start a business preparing and selling fast food in the Balkan region, particularly in the countries of Serbia, Montenegro and Croatia. Later we plan to expand into the USA, particularly the states of Florida and Illinois, in order to provide the settled Balkan communities and wider American community with authentic and traditional Serbian fast food, which includes barbequed beef, pork, lamb, chicken, hamburgers, cheeseburgers, minced meat pies, French fries and traditional Serbian salads, pickles and garnish.
Miami Days Corp would rent space at Save Jovsica 9E, Zvezdara 11000 in the city of Belgrade in Serbia from a relative of Bojan Didic named Slavko Didic for $1000/month.
Since Miami Days Corp had no cash or revenues, the company decided to do a public offering to sell up to 10,000,000 shares at $.01/share raising up to $100,000. In reality, Miami Days Corp was yet another shell scheme with a flimsy forward looking business plan that would intentionally fail so that the shell could be used for a future insider enrichment scheme.
On September 11, 2012, an S-1 was filed to take Miami Days Corp public and to register those 10,000,000 shares for sale to some hand picked seed shareholders probably from Serbia.
The attorney letter was provided by David Lubin who has been showing up in a lot of our research lately. Some tickers linked to David Lubin that have already become paid promotions include BIZM, FUEG, GRPH, LTUM, and MSTG among others. See a more complete list of Lubin tickers on our list of attorneys to follow for a future paid promotion.
Auditor, Ronald R Chadwick P.C. handled all the accounting services.
Miami Days Corp told that SEC that that would need to raise a minimum of $33,700 to conduct their proposed operations for a minimum period of one year. That means they would have to sell no less than 3,370,000 shares or the business plan would fail. Without even looking I can guarantee you they would not end up selling at least 3,370,000 shares because that is how these schemes work. They throw some bogus business plan at the SEC who naively approves the plan then they intentionally sell less shares than what it would take to move forward with the business plan allowing the shell to conveniently fail and move on to the next phases of the insider enrichment scheme. The SEC makes if far too easy.
After a few amendments, the SEC approved the S-1 filing on February 8, 2013. Miami Days Corp was given the trading symbol MIDY.
One month after Miami Days Corp was granted public trading status, another Serbian citizen named Sara Ilic was brought on board as the secretary.
Sara Ilic had just finished her schooling in 2011 studying at an Arts Academy in Serbia. According to her bio, from 2009 to 2010 Sara Ilic worked as illustrator for the magazine “Zvonce” (Publisher: Patriarchate of Serbia). In 2010 she held a job as administrator in an agency of layout and calligraphy design. From 2011 to 2013 she worked as customer care representative with main activities to provide support with customer queries and other related tasks including outbound telemarketing calls
As expected, MIDY only managed to sell 1,355,000 shares to the Serbian seed shareholders raising $13,550. That was well short of the minimum 3,370,000 shares ($33,700) needed to initiate their business plan. $10,000 of the $13,550,000 raised would go to Lubin and Chadwick for their services and to cover the filing fees.
It used to be that these shells would sit in waiting for a couple of years or more, but lately these insider enrichment schemes have been going in fast motion. MIDY would waste no time moving on to the next stages of this insider enrichment scheme moving ahead in a matter of just 6 months.
Change of Control
On August 26, 2013, Bojan Didic resigned from all of his positions and Gloria Simov was appointed a director, president and chief executive officer of MIDY.
Born in Rome, Italy, and growing up in Southern California, according to her bio, Gloria Simov has an extensive international professional network. Over the last five years Gloria Simov has accumulated experience in many facets of the Medical Industry. Since November 30, 2012, Ms. Simov has served as director, President and CEO of Life Stem Genetics, Inc. a company purportedly involved in providing Stem Cell Therapy treatment.
After taking over as the CEO of the MIDY shell, Gloria Simov immediately signed a letter of intent to acquire her Life Stem Genetics Inc entity.
Life Stem Genetics Inc is a North Dakota company that was only just created on November 30, 2012.
Life Stem Genetics Inc was incorporated with the help of David DeLoach, owner of Corp95, LLC. David DeLoach has been involved in incorporating over 2,000 shell companies a year through a mailbox center in Dana Point, California according to this article.
David DeLoach was recently involved in incorporating Freedom Petroleum Inc (FPET) which is a Scott Olson shell that just got its trading symbol.
The acquisition agreement with Life Stem Genetics Inc would involve the Life Stem Genetics Inc shareholders receiving common stock in MIDY equal to 60% of the outstanding stock (2,032,500 shares) in exchange for all of the outstanding stock of Life Stem Genetics Inc (1,100,000 shares) making Life Stem Genetics Inc a wholly owned subsidiary of MIDY. As part of the acquisition Bojan Divic would cancel his 4,000,000 shares.
The 1,100,000 shares of Life Stem Genetics Inc stock were controlled as follows:
- Gloria Simov - 500,000 shares becoming 923,864 MIDY shares
- Nathan Merry - 500,000 shares becoming 923,864 MIDY shares
- Prince Marketing Group Limited (an anonymous Belize entity) - 100,000 shares becoming 184,772 MIDY shares
The acquisition would also include a private placement to raise $500,000.
The acquisition agreement gave MIDY the opportunity to get FINRA to approve a 13:1 forward split helping the seed shareholders to improve their holdings to 17,615,000 shares costing just $.00077/share. Those seed shareholders will have the opportunity to make huge profits in the future most likely with the help of a pump&dump paid promotion.
The new share count will look as follows upon the completion of the share exchange agreement and forward split:
Authorized - 250,000,000 shares
Gloria Simov - 12,010,232 shares
Nathan Merry -12,010,232 shares
Prince Marketing Group Limited (an anonymous Belize entity) - 2,402,036 shares
Seed Shareholders - 17,615,000 shares (free trading) costing $.00077/share
More about Life Stem Genetics Inc
The Life Stem Genetics Inc website can be found here.
According to that website, Life Stem’s stem cell therapy approach is based on proprietary and patented technology using a powerful combination of procedures and nutrient rich supplements. Life Stem will administer I.V. as well as joint injections conducted by MD’s and surgeons. This regenerative procedure has been exclusively developed and tested to promote spinal, joint, organ health and longevity by using the patient’s own platelet rich blood cells and ASCs. The Center will offer banking services for maintenance programs, offer alternative cancer therapy as well as diagnostics. Our procedure helps regenerate and maintain a healthy quality lifestyle with the possibility of returning back to normal activities of daily living. Stem cell therapies have a huge potential to help treat diseases or conditions for which few treatment options are available.
Stem cell-based therapies offer the promise of revolutionizing medicine and provide new ways to treat previously untreatable diseases and ailments, from diabetes to Parkinson’s disease, eye disorders or spinal cord injury and cancer. Adult Stem Cells derived from the patient’s own body are used in a simple procedure that is completed within 4 hours. Fat is extracted from the patient’s abdomen, the stem cells are isolated and returned through a simple intravenous drip.
The treatments that will be offered include:
- Degenerative conditions
- Cancer treatments
- Weight Loss
- Anti-Aging Stem Cell Therapy
- Anti-Viral Therapy
- Adistem stem cell treatments for orthopedics, neurological, lung diseases
The Life Stem Generics Inc management team includes:
We have yet to see any financial records for Life Stem Genetics Inc, but being that the entity is less than a year old, I do not expect that we'll see any revenues on the books when those financials do show up. Despite the experienced advisory team and the good sounding business plan, I am inclined to believe that in reality Life Stem Genetics Inc will be just another penny stock that falls far far short of their forward looking projections and optimistic goals.
MIDY already has a new name, Life Stem Genetics Inc. The forward split will clear in exactly 30 days at which point Life Stem Genetics Inc will get its new symbol, LIFS. After that, because of the David Lubin connect, the obvious shell scheme set-up, the anonymous Belize entity, and the 13:1 forward split, we expect that at some point Life Stem Genetics will become the subject of a paid promotion. The size of the float suggests that it will be a newsletter promotion that could include hard mailers probably starting in the $.70 - $.90 range. Today we are adding Life Stem Genetics Inc to our watch list for a future paid promotion.